Vitamin E deficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Lactating women; normal delivery; term delivery; aged 18 to 40 years.
Exclusion criteria
Exclusion criteria: Women with any clinical sign of disease; infections; syphilis; HIV; gastrointestinal diseases; liver disease; heart disease; diabetes; hypertension; cancer; mental disorder; twin pregnancie; newborn with fetal malformations; history of abortion; use of antithrombotics; use of supplements containing vitamin E during pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Increased alpha-tocopherol levels in blood and mother's milk after administration of supplemental vitamin E, within 60 days postpartum. For determining the expected outcome, the efficiency of the two supplementation schemes adopted in increasing and maintaining the alpha-tocopherol levels in the blood and maternal milk in the given time period will be evaluated. Will be used statistical tools to observe variation in alpha-tocopherol levels of the control group, supplemented 1 and 2 supplemented. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: increase and maintain the most significant level of vitamin E in breast milk of lactating group supplemented 2. To realize the expected outcome will be used statistical tools to compare the supplementation scheme 2 (administration of 01 400 IU capsule on the 1st and 20th days postpartum) efficiency with supplementation scheme 1 (administration of 01 400 IU capsule on the 1st day postpartum). | — |
Countries
Brazil
Contacts
Universidade Federal do Rio Grande do Norte